Considering the marked difference in RTK dominance in isogenic epithelial and mesenchymal pairs of lung cancer cell lines generated through in vitro acquired TKI resistance [49, 50], it is likely that TKI insensitivity in these models is related to the emergence of distinct RTK pathways as growth drivers including FGFR family members and AXL. This evidence concerns the gene AXL and lung carcinoma.